HemaCare (HEMA) Short Interest Ratio & Short Volume → Gold Mania (From Stansberry Research) (Ad) Free HEMA Stock Alerts $25.31 +0.15 (+0.60%) (As of 01/3/2020) Add Compare Share Share Short InterestStock Analysis HemaCare Short Interest DataCurrent Short Volume300 sharesPrevious Short Volume1,300 sharesChange Vs. Previous Month-76.92%Dollar Volume Sold Short$7,593.00Short Interest Ratio / Days to Cover0.0Last Record DateDecember 31, 2019Outstanding Shares13,691,000 sharesPercentage of Shares Shorted0.00%Today's Trading Volume5,400 sharesAverage Trading Volume39,950 sharesToday's Volume Vs. Average14% Short Selling HemaCare ? Sign up to receive the latest short interest report for HemaCare and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatHEMA Short Interest Over TimeHEMA Days to Cover Over TimeHEMA Percentage of Float Shorted Over Time Ad Stansberry ResearchGlobal crypto currency reset (41 major banks signed up)Behind closed doors, at least 41 major US banks have signed up to a strange new crypto project... Here's everything you need to know. HemaCare Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 12/31/2019300 shares $7,593.00 -76.9%N/A0 $25.31 HEMA Short Interest - Frequently Asked Questions What is HemaCare's current short interest? Short interest is the volume of HemaCare shares that have been sold short but have not yet been closed out or covered. As of December 31st, investors have sold 300 shares of HEMA short. Learn More on HemaCare's current short interest. Is HemaCare's short interest increasing or decreasing? HemaCare saw a decline in short interest in the month of December. As of December 31st, there was short interest totaling 300 shares, a decline of 76.9% from the previous total of 1,300 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does HemaCare's short interest compare to its competitors? Here is how the short interest of companies in the sector of "medical" compare to HemaCare: Tactile Systems Technology, Inc. (4.76%), Mereo BioPharma Group plc (2.22%), Caribou Biosciences, Inc. (14.24%), Solid Biosciences Inc. (3.47%), Tenaya Therapeutics, Inc. (5.41%), Mersana Therapeutics, Inc. (8.72%), Rani Therapeutics Holdings, Inc. (14.69%), Aura Biosciences, Inc. (6.50%), UroGen Pharma Ltd. (17.91%), ModivCare Inc. (6.65%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Tesla, Inc. ($14.83 billion), Netflix, Inc. ($7.72 billion), Advanced Micro Devices, Inc. ($4.69 billion), Charter Communications, Inc. ($4.67 billion), Microchip Technology Incorporated ($3.40 billion), Centene Co. ($3.26 billion), Match Group, Inc. ($2.67 billion), Teladoc Health, Inc. ($2.31 billion), Snap Inc. ($2.24 billion), and Wayfair Inc. ($2.22 billion). View all of the most shorted stocks. What does it mean to sell short HemaCare stock? Short selling HEMA is an investing strategy that aims to generate trading profit from HemaCare as its price is falling. HEMA shares are trading up $0.15 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against HemaCare? A short squeeze for HemaCare occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of HEMA, which in turn drives the price of the stock up even further. How often is HemaCare's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including HEMA, twice per month. The most recent reporting period available is December, 31 2019. More Short Interest Resources from MarketBeat Related Companies: TCMD Short Squeeze MREO Short Squeeze CRBU Short Squeeze SLDB Short Squeeze TNYA Short Squeeze MRSN Short Squeeze RANI Short Squeeze AURA Short Squeeze URGN Short Squeeze MODV Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (OTCMKTS:HEMA) was last updated on 5/3/2024 by MarketBeat.com Staff From Our PartnersElon to Transform U.S. Economy? Porter & CompanyBiden to Launch “FedNOW” [Move Your Money Now]Priority GoldUrgent Nvidia WarningAltimetryAutomatic Income (from home)Awesomely, LLCCould Your Accounts Be Frozen?Allegiance GoldThe A.I. story nobody is telling you (Read ASAP)TradeSmithThe Gold Grab of the CenturyColonial MetalsForget Bitcoin: This $8 Stock Is the Next Big ThingBehind the Markets